Company intelligence / Profile preview

Glenmark Holding

Mumbai, India

Ownership: Private
Employees: ~14000
Development stage: Other

Overview

Glenmark Pharmaceuticals is an active, commercial-stage Indian pharmaceutical company with a global presence, focusing on oncology, dermatology, and respiratory diseases. It develops and manufactures small molecules, monoclonal antibodies, and biosimilars, and operates across generics, specialty, and OTC segments.

Therapeutic areas: OncologyEndocrinologyPulmonologyDermatology
Modalities: Small moleculeMonoclonal antibodyBiosimilar
Industry: Biotech

Partnerships

Licensing agreements with major pharmaceutical companies (specific partners in North America and Japan for respiratory drug)German Merck (for diabetes drug)

Beyond the preview

Go deeper on Glenmark Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glenmark Holding.

Explore the full profile